X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AJANTA PHARMA with Wockhardt - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AJANTA PHARMA vs WOCKHARDT LTD. - Comparison Results

WOCKHARDT LTD. 
   Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AJANTA PHARMA WOCKHARDT LTD. AJANTA PHARMA/
WOCKHARDT LTD.
 
P/E (TTM) x 18.4 -9.6 - View Chart
P/BV x 4.2 1.9 221.5% View Chart
Dividend Yield % 0.0 1.7 -  

Financials

 AJANTA PHARMA   WOCKHARDT LTD.
EQUITY SHARE DATA
    AJANTA PHARMA
Mar-18
WOCKHARDT LTD.
Mar-17
AJANTA PHARMA/
WOCKHARDT LTD.
5-Yr Chart
Click to enlarge
High Rs1,8181,129 161.0%   
Low Rs1,106627 176.4%   
Sales per share (Unadj.) Rs239.5363.1 65.9%  
Earnings per share (Unadj.) Rs52.8-20.4 -258.2%  
Cash flow per share (Unadj.) Rs59.5-7.0 -853.1%  
Dividends per share (Unadj.) Rs010.00 0.0%  
Dividend yield (eoy) %01.1 0.0%  
Book value per share (Unadj.) Rs230.0301.8 76.2%  
Shares outstanding (eoy) m88.77110.55 80.3%   
Bonus/Rights/Conversions -IS-  
Price / Sales ratio x6.12.4 252.5%   
Avg P/E ratio x27.7-42.9 -64.5%  
P/CF ratio (eoy) x24.6-125.9 -19.5%  
Price / Book Value ratio x6.42.9 218.6%  
Dividend payout %0-48.9 0.0%   
Avg Mkt Cap Rs m129,78297,063 133.7%   
No. of employees `0006.86.8 100.4%   
Total wages/salary Rs m3,7659,665 39.0%   
Avg. sales/employee Rs Th3,128.45,931.8 52.7%   
Avg. wages/employee Rs Th554.01,428.1 38.8%   
Avg. net profit/employee Rs Th689.7-334.0 -206.5%   
INCOME DATA
Net Sales Rs m21,25840,146 53.0%  
Other income Rs m2421,143 21.1%   
Total revenues Rs m21,49941,289 52.1%   
Gross profit Rs m6,584128 5,143.7%  
Depreciation Rs m5961,489 40.0%   
Interest Rs m42,253 0.2%   
Profit before tax Rs m6,226-2,472 -251.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,539-211 -729.1%   
Profit after tax Rs m4,686-2,260 -207.3%  
Gross profit margin %31.00.3 9,714.1%  
Effective tax rate %24.78.5 289.4%   
Net profit margin %22.0-5.6 -391.5%  
BALANCE SHEET DATA
Current assets Rs m12,23646,160 26.5%   
Current liabilities Rs m3,46119,258 18.0%   
Net working cap to sales %41.367.0 61.6%  
Current ratio x3.52.4 147.5%  
Inventory Days Days60101 59.8%  
Debtors Days Days8494 89.8%  
Net fixed assets Rs m11,14040,165 27.7%   
Share capital Rs m177553 32.0%   
"Free" reserves Rs m20,23732,814 61.7%   
Net worth Rs m20,41433,367 61.2%   
Long term debt Rs m1031,903 0.0%   
Total assets Rs m24,48689,687 27.3%  
Interest coverage x1,519.4-0.1 -1,564,344.3%   
Debt to equity ratio x01.0 0.1%  
Sales to assets ratio x0.90.4 193.9%   
Return on assets %19.20 -223,121.5%  
Return on equity %23.0-6.8 -338.9%  
Return on capital %30.5-0.3 -9,098.9%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m11,6679,121 127.9%   
Fx outflow Rs m1,6162,133 75.7%   
Net fx Rs m10,0526,988 143.9%   
CASH FLOW
From Operations Rs m2,854-2,695 -105.9%  
From Investments Rs m-2,604-6,863 37.9%  
From Financial Activity Rs m-212,545 -0.0%  
Net Cashflow Rs m2483,010 8.2%  

Share Holding

Indian Promoters % 73.8 74.5 99.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 1.6 2.3 67.4%  
FIIs % 7.6 7.7 98.7%  
ADR/GDR % 0.0 0.1 -  
Free float % 17.0 15.4 110.4%  
Shareholders   20,968 67,757 30.9%  
Pledged promoter(s) holding % 4.4 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AJANTA PHARMA With:   STERLING BIOTECH  SANOFI INDIA  ALKEM LABORATORIES  ORCHID PHARMA LTD  NOVARTIS  

Compare AJANTA PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Trade Marginally Lower; Metal Sector Down 2.7%(12:30 pm)

Share markets in India are presently trading marginally lower. Sectoral indices are trading on a negative note with stocks in the metal sector and telecom sector witnessing maximum selling pressure.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

How to Avoid a 90% Loss Suffered by This Super Investor(The 5 Minute Wrapup)

Jul 12, 2018

Blindly following super investors is a dangerous game to play. Here's how you can avoid such mistakes.

The Answer to Your Wealth Worries: Small Caps (Especially Now)(Profit Hunter)

Jul 10, 2018

If you're worried about the markets - you are on the wrong track. This is opportunity - put your wealth-building hat on, instead - Richa shows you how...

The Multiple Problems with the Minimum Support Price (MSP) System(Vivek Kaul's Diary)

Jul 11, 2018

The price signals that MSP sends out, creates its own set of problems.

New Fund Offer - ICICI Prudential Pharma Healthcare and Diagnostics Fund - Should You Invest?(Outside View)

Jul 6, 2018

ICICI AMC launches an open -ended equity fund following Pharma, Healthcare, Diagnostic and allied theme.

When Disappointment Panda is Around. Buy Quality Stock like This!(Chart Of The Day)

Jul 6, 2018

Buy Companies that can fight all kinds of Pandas and Bears in the long run.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

AJANTA PHARMA SHARE PRICE


Jul 18, 2018 02:11 PM

TRACK AJANTA PHARMA

  • Track your investment in AJANTA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AJANTA PHARMA - J.B.CHEMICALS COMPARISON

COMPARE AJANTA PHARMA WITH

MARKET STATS